-
Electronic (PDF)
-
Site License
-
Enterprisewide
France Cardiovascular Devices Market Analysis and Forecasts to 2015
GlobalData, July 2009, Pages: 213
France Cardiovascular Devices Market Analysis and Forecasts to 2015
Summary
Our “France Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the France cardiovascular devices market. The report provides market landscape, competitive landscape and market trends information on seven market categories including cardiac rhythm management, cardiovascular monitoring and diagnostic devices, cardiovascular prosthetic devices, cardiovascular surgery, interventional cardiology, peripheral vascular devices and electrophysiology. The report provides comprehensive information on the key trends affecting these categories, and key analytical insight on the market dynamics. The report also reviews the competitive landscape in terms of mergers and acquisitions, pipeline products and technology offerings.
Scope
- Forecasts & Analysis of the France cardiovascular devices market to 2015.
- Market segmentation by Cardiac Rhythm Management (CRM), Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Interventional Cardiology, Peripheral Vascular Devices and Electrophysiology.
- Market Analysis from 2001 to 2008, including new updated 2008 data.
- Analysis of the leading companies and competitive landscape including 2008 company market share analysis.
- Analysis of key cardiovascular pipeline products, new technologies and clinical trials.
- Insight into the key mergers and acquisitions (M&As), partnerships, venture capital and private equity investments.
- Qualitative analysis of market drivers, market limiters regulatory issues and future outlook.
Reasons to buy
- Understand what the new growth opportunities are within the France cardiovascular devices market.
- Develop a clear knowledge & understanding of the France cardiovascular devices competitor landscape and how this will change to 2015.
- Identify acquisition opportunities across the France cardiovascular devices market.
- Identify key winners and losers and who is best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Make more informed business decisions from the insightful and in-depth analysis of the market and the factors shaping it.
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets Covered in the Report
3.1 Cardiovascular Devices
3.2 Cardiac Rhythm Management
3.2.1 Pacemakers
3.2.2 Implantable Cardioverter Defibrillator (ICD)
3.2.3 Cardiovascular Pacing and ICD Leads
3.2.4 Cardiac Resynchronization Therapy
3.3 Cardiovascular monitoring and diagnostic devices
3.3.1 ECG Monitoring Equipment
3.3.2 ECG Stress Testing Systems
3.3.3 Holter Monitoring Systems
3.3.4 Event Monitoring Systems
3.4 Cardiovascular prosthetic device
3.4.1 Prosthetic heart valves
3.4.2 Cardiac Valve Repair
3.4.3 Cardiac assist devices
3.5 Cardiovascular Surgery
3.5.1 Beating Heart Systems
3.5.2 Perfusion Systems
3.5.3 Cardiac Ablation Devices
3.5.4 Cardiopulmonary Bypass Equipment
3.5.5 Perfusion Disposables
3.6 Electrophysiology
3.6.1 Electrophysiology diagnostic catheter
3.6.2 Electrophysiology ablation catheter
3.6.3 Electrophysiology lab systems
3.7 Interventional cardiology
3.7.1 Coronary Stents
3.7.2 Cardiac Catheters
3.7.3 Percutaneous Transluminal Coronary Balloon (PTCA) Balloon Catheters
3.7.4 Coronary Guidewire
3.7.5 Arteriotomy Closure Devices
3.8 Peripheral vascular devices
3.8.1 Peripheral Vascular Stents
3.8.2 Inferior Vena Cava Filter
3.8.3 PTA Balloon
3.8.4 Aortic Stent Graft
3.8.5 Embolic Protection Device
3.8.6 Synthetic Surgical Grafts
3.8.7 Peripheral Guidewire
4 Healthcare Sector Review
4.1 Healthcare Sector Review
4.2 Healthcare Expenditure
4.3 Healthcare Infrastructure
4.3.1 Healthcare Personnel Data
4.3.2 Healthcare Facilities Data
4.4 Healthcare Policy
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification
5.1.2 Conformity Assessment Process
5.1.3 Registration Fee
5.1.4 Registration Period
5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
6.1 Pricing and Reimbursement Policies
7 Distribution Structure
7.1 France Medical Equipment Distribution Structure
8 Cardiovascular Devices In France
8.1 Cardiovascular Devices, France, Overall Revenue ($ mn), 2000-2015
8.2 Cardiovascular Devices, France, Overall Volume (Units), 2000-2015
8.3 Cardiovascular Devices Market, France Cross Category Analysis
8.4 Cardiovascular Devices, France, Company Share (2006-2007)
9 Cardiac Rhythm Management In France
9.1 Cardiac Rhythm Management Overall Revenue (2000-2015)
9.1.1 Cardiac Resynchronisation Therapy, Revenue ($ mn), 2000-2015
9.1.2 Implantable Cardioverter Defibrillator, Revenue ($ mn), 2000-2015
9.1.3 Pacemaker, Revenue ($ mn), 2000-2015
9.2 Cardiac Rhythm Management Overall Volume (2000-2015)
9.2.1 Cardiac Resynchronisation Therapy, Volume (Units) 2000-2015
9.2.2 Implantable Cardioverter Defibrillator, Volume (Units), 2000-2015
9.2.3 Pacemaker, Volume (Units), 2000-2015
9.3 Cardiac Rhythm Management Average Price (2000-2015)
9.4 Cardiac Rhythm Management Market Dynamics
9.4.1 Market Drivers
9.4.2 Market Restraints
9.5 Cardiac Rhythm Management Distribution Share (2007-2008)
9.6 Cardiac Rhythm Management, France, Company Share (2006-2007)
10 Cardiovascular Monitoring and Diagnostic Devices In France
10.1 Cardiovascular Monitoring and Diagnostic Devices Overall Revenue (2000-2015)
10.2 Cardiovascular Monitoring and Diagnostic Devices Overall Volume (2000-2015)
10.3 Cardiovascular Monitoring and Diagnostic Devices Average Price (2000-2015)
10.4 Cardiovascular Monitoring and Diagnostic Devices Distribution Share (2007-2008)
10.5 Cardiovascular Monitoring and Diagnostic Devices, France, Company Share (2006-2007)
11 Cardiovascular Prosthetic Devices In France
11.1 Cardiovascular Prosthetic Devices Overall Revenue (2000-2015)
11.1.1 Cardiac Assist Devices, Revenue ($ mn), 2000-2015
11.1.2 Prosthetic Heart Valve, Revenue ($ mn), 2000-2015
11.2 Cardiovascular Prosthetic Devices Overall Volume (2000-2015)
11.2.1 Cardiac Assist Devices, Volume (Units), 2000-2015
11.2.2 Prosthetic Heart Valve, Volume (Units), 2000-2015
11.3 Cardiovascular Prosthetic Devices Average Price (2000-2015)
11.4 Cardiovascular Prosthetic Devices Market Dynamics
11.4.1 Market Drivers
11.4.2 Market Restraints
11.5 Cardiovascular Prosthetic Devices Distribution Share (2007-2008)
11.6 Cardiovascular Prosthetic Devices, France, Company Share (2006-2007)
12 Cardiovascular Surgery In France
12.1 Cardiovascular Surgery Overall Revenue (2000-2015)
12.1.1 Perfusion Disposables, Revenue ($ mn), 2000-2015
12.2 Cardiovascular Surgery Overall Volume (2000-2015)
12.2.1 Perfusion Disposables Overall Volume (2000-2015)
12.3 Cardiovascular Surgery Average Price (2000-2015)
12.4 Cardiovascular Surgery Market Dynamics
12.4.1 Market Drivers
12.4.2 Market Restraints
12.5 Cardiovascular Surgery Distribution Share (2007-2008)
12.6 Cardiovascular Surgery, France, Company Share (2006-2007)
13 Electrophysiology In France
13.1 Electrophysiology Overall Revenue (2000-2015)
13.2 Electrophysiology Overall Volume (2000-2015)
13.3 Electrophysiology Average Price (2000-2015)
13.4 Electrophysiology Market Dynamics
13.4.1 Market Drivers
13.4.2 Market Restraints
13.5 Electrophysiology Distribution Share (2007-2008)
13.6 Electrophysiology, France, Company Share (2006-2007)
14 Interventional Cardiology In France
14.1 Interventional Cardiology Overall Revenue (2000-2015)
14.1.1 Cardiac Catheter, Revenue ($ mn), 2000-2015
14.1.2 Coronary Stent, Revenue ($ mn), 2000-2015
14.1.3 PTCA Balloon, Revenue ($ mn), 2000-2015
14.2 Interventional Cardiology Overall Volume (2000-2015)
14.2.1 Cardiac Catheter, Volume (Units), 2000-2015
14.2.2 Coronary Stent, Revenue ($ mn), 2000-2015
14.2.3 PTCA Balloon, Revenue ($ mn), 2000-2015
14.3 Interventional Cardiology Average Price (2000-2015)
14.4 Interventional Cardiology Market Dynamics
14.4.1 Market Drivers
14.4.2 Market Restraints
14.5 Interventional Cardiology Distribution Share (2007-2008)
14.6 Interventional Cardiology, France, Company Share (2006-2007)
15 Peripheral Vascular Devices In France
15.1 Peripheral Vascular Devices Overall Revenue (2000-2015)
15.2 Peripheral Vascular Devices Overall Volume (2000-2015)
15.3 Peripheral Vascular Devices Average Price (2000-2015)
15.4 Peripheral Vascular Devices Market Dynamics
15.4.1 Market Drivers
15.4.2 Market Restraints
15.5 Peripheral Vascular Devices Distribution Share (2007-2008)
15.6 Peripheral Vascular Devices, France, Company Share (2006-2007)
16 Overview of Key Companies in France Cardiovascular Market
16.1 Cordis Corporation
16.1.1 Company Overview
16.1.2 Cordis Corporation Pipeline Products
16.2 Boston Scientific Corporation
16.2.1 Company Overview
16.2.2 Value Chain Analysis
16.3 Boston Scientific Corporation
16.3.1 Boston Scientific Corporation Pipeline Products by Equipment Type
16.3.2 Boston Scientific Corporation Pipeline Products By Development Stage
16.3.3 Boston Scientific Corporation Pipeline Products By Therapy Area
16.3.4 Boston Scientific Corporation Pipeline Products By Clinical Trials
16.3.5 Boston Scientific Corporation Pipeline Products By News Summary
16.4 Medtronic, Inc.
16.4.1 Company Overview
16.4.2 Value Chain Analysis
16.4.3 Medtronic, Inc. Pipeline Products
16.5 Abbott Laboratories
16.5.1 Company Overview
16.5.2 Value Chain Analysis
16.5.3 Abbott Laboratories Pipeline Products
16.6 Terumo Corporation
16.6.1 Company Overview
16.6.2 Value Chain Analysis
16.6.3 Terumo Corporation Pipeline Products
16.7 Sorin S.p.A.
16.7.1 Company Overview
16.7.2 Value Chain Analysis
16.7.3 Sorin Group Pipeline Products
16.8 Balt Extrusion
16.8.1 Company Overview
16.9 COMEPA
16.9.1 Company Overview
16.10 HEXACATH
16.10.1 Company Overview
16.11 Microval Company Profile
16.11.1 Company Overview
16.12 Minvasys Company Profile
16.12.1 Company Overview
16.12.2 Minvasys Pipeline Products
16.13 Novacor
16.13.1 Company Overview
16.14 Stentys, S.A.S.
16.14.1 Company Overview
16.14.2 Stentys, S.A.S. Pipeline Products
17 Appendix
17.1 Research Methodology
17.2 Coverage
17.3 Secondary Research
17.4 Primary Research
17.5 Models
17.6 Forecasts
17.7 Expert Panels
17.8 Currency Conversion
17.9 Contact Us
17.10 Disclaimer
Executive Summary
1.1 List of Tables
Table 1: Number of Doctors by Specialty in France, 2003-2007 29
Table 2: Number of Hospital Wards by Specialty in France, 2003-2007 30
Table 3: Cardiovascular Devices, France, Overall Revenue ($ mn), Historic, 2000-2008 50
Table 4: Cardiovascular Devices, France, Overall Revenue ($ mn), Forecast, 2008-2015 52
Table 5: Cardiovascular Devices, France, Overall Volume (Units), Historic, 2000-2008 53
Table 6: Cardiovascular Devices, France, Overall Volume (Units), Forecast, 2008-2015 55
Table 7: Cardiovascular Devices, France, Portfolio Analysis, 2000-2015 56
Table 8: Cardiovascular Devices, France, Company Share by Revenue ($ mn), 2006-2007 57
Table 9: Cardiac Rhythm Management, France, Revenue ($ mn) by Segment, Historic, 2000-2008 58
Table 10: Cardiac Rhythm Management, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 60
Table 11: Cardiac Resynchronisation Therapy, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 61
Table 12: Cardiac Resynchronisation Therapy, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 62
Table 13: Implantable Cardioverter Defibrillator, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 63
Table 14: Implantable Cardioverter Defibrillator, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 64
Table 15: Pacemaker, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 65
Table 16: Pacemaker, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 66
Table 17: Cardiac Rhythm Management, France, Volume (Units) by Segment, Historic, 2000-2008 67
Table 18: Cardiac Rhythm Management, France, Volume (Units) by Segment, Forecast, 2008-2015 68
Table 19: Cardiac Resynchronisation Therapy, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 69
Table 20: Cardiac Resynchronisation Therapy, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 70
Table 21: Implantable Cardioverter Defibrillator, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 71
Table 22: Implantable Cardioverter Defibrillator, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 72
Table 23: Pacemaker, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 73
Table 24: Pacemaker, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 74
Table 25: Cardiac Rhythm Management, France, Average Price ($), Historic, 2000-2008 75
Table 26: Cardiac Rhythm Management, France, Average Price ($), Forecast, 2008-2015 75
Table 27: Cardiac Rhythm Management, France, Distribution Share by Revenue ($mn), 2007-2008 77
Table 28: Cardiac Rhythm Management, France, Company Share by Revenue ($ mn), 2006-2007 78
Table 29: Cardiovascular Monitoring and Diagnostic Devices, France, Revenue ($ mn) by Segment, Historic, 2000-2008 80
Table 30: Cardiovascular Monitoring and Diagnostic Devices, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 81
Table 31: Cardiovascular Monitoring and Diagnostic Devices, France, Volume (Units) by Segment, Historic, 2000-2008 82
Table 32: Cardiovascular Monitoring and Diagnostic Devices, France, Volume (Units) by Segment, Forecast, 2008-2015 83
Table 33: Cardiovascular Monitoring and Diagnostic Devices, France, Average Price ($), Historic, 2000-2008 84
Table 34: Cardiovascular Monitoring and Diagnostic Devices, France, Average Price ($), Forecast, 2008-2015 84
Table 35: Cardiovascular Monitoring and Diagnostic Devices, France, Distribution Share by Revenue ($mn), 2007-2008 85
Table 36: Cardiovascular Monitoring and Diagnostic Devices, France, Company Share by Revenue ($ mn), 2006-2007 86
Table 37: Cardiovascular Prosthetic Devices, France, Revenue ($ mn) by Segment, Historic, 2000-2008 87
Table 38: Cardiovascular Prosthetic Devices, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 89
Table 39: Cardiac Assist Devices, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 90
Table 40: Cardiac Assist Devices, France, Revenues ($ mn) by Sub-Segment, Forecast, 2008-2015 91
Table 41: Prosthetic Heart Valve, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 92
Table 42: Prosthetic Heart Valve, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 93
Table 43: Cardiovascular Prosthetic Devices, France, Volume (Units), Historic by Segment, 2000-2008 94
Table 44: Cardiovascular Prosthetic Devices, France, Volume (Units) by Segment, Forecast, 2008-2015 95
Table 45: Cardiac Assist Devices, France, Volume (Units) by Sub-Segment by Segment, Historic, 2000-2008 96
Table 46: Cardiac Assist Devices, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 97
Table 47: Prosthetic Heart Valve, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 98
Table 48: Prosthetic Heart Valve, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 99
Table 49: Cardiovascular Prosthetic Devices, France, Average Price ($), Historic, 2000-2008 100
Table 50: Cardiovascular Prosthetic Devices, France, Average Price ($), Forecast, 2008-2015 100
Table 51: Cardiovascular Prosthetic Devices, France, Distribution Share by Revenue ($mn), 2007-2008 102
Table 52: Cardiovascular Prosthetic Devices, France, Company Share by Revenue ($ mn), 2006-2007 103
Table 53: Cardiovascular Surgery, France, Revenue ($ mn) by Segment, Historic, 2000-2008 104
Table 54: Cardiovascular Surgery, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 106
Table 55: Perfusion Disposables, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2008 107
Table 56: Perfusion Disposables, France, Revenues ($ mn) by Sub-Segment, Forecast, 2008-2015 108
Table 57: Cardiovascular Surgery, France, Volume (Units) by Segment, Historic, 2000-2008 109
Table 58: Cardiovascular Surgery, France, Volume (Units) by Segment, Forecast, 2008-2015 110
Table 59: Perfusion Disposables, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 111
Table 60: Perfusion Disposables, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 112
Table 61: Cardiovascular Surgery, France, Average Price ($), Historic, 2000-2008 113
Table 62: Cardiovascular Surgery, France, Average Price ($), Forecast, 2008-2015 113
Table 63: Cardiovascular Surgery, France, Distribution Share by Revenue ($mn), 2007-2008 115
Table 64: Cardiovascular Surgery, France, Company Share by Revenue ($ mn), 2006-2007 116
Table 65: Electrophysiology, France, Revenue ($ mn) by Segment, Historic, 2000-2008 117
Table 66: Electrophysiology, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 118
Table 67: Electrophysiology, France, Volume (Units) by Segment, Historic, 2000-2008 119
Table 68: Electrophysiology, France, Volume (Units) by Segment, Forecast, 2008-2015 120
Table 69: Electrophysiology, France, Average Price ($), Historic, 2000-2008 121
Table 70: Electrophysiology, France, Average Price ($), Forecast, 2008-2015 121
Table 71: Electrophysiology, France, Distribution Share by Revenue ($mn), 2007-2008 123
Table 72: Electrophysiology, France, Company Share by Revenue ($ mn), 2006-2007 124
Table 73: Interventional Cardiology, France, Revenue ($ mn) by Segment, Historic, 2000-2008 126
Table 74: Interventional Cardiology, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 127
Table 75: Cardiac Catheter, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 128
Table 76: Cardiac Catheter, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 129
Table 77: Coronary Stent, France, Revenues ($ mn) by Sub-Segment, Historic, 2000-2008 130
Table 78: Coronary Stent, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 131
Table 79: PTCA Balloon, France, Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 132
Table 80: PTCA Balloon, France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 133
Table 81: Interventional Cardiology, France, Volume (Units) by Segment, Historic, 2000-2008 134
Table 82: Interventional Cardiology, France, Volume (Units) by Segment, Forecast, 2008-2015 135
Table 83: Cardiac Catheter, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 136
Table 84: Cardiac Catheter, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 137
Table 85: Coronary Stent, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 138
Table 86: Coronary Stent, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 139
Table 87: PTCA Balloon, France, Volume (Units) by Sub-Segment, Historic, 2000-2008 140
Table 88: PTCA Balloon, France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 141
Table 89: Interventional Cardiology, France, Average Price ($), Historic, 2000-2008 142
Table 90: Interventional Cardiology, France, Average Price ($), Forecast, 2008-2015 143
Table 91: Interventional Cardiology, France, Distribution Share by Revenue ($mn), 2007-2008 145
Table 92: Interventional Cardiology, France, Company Share by Revenue ($ mn), 2006-2007 146
Table 93: Peripheral Vascular Devices, France, Revenue ($ mn) by Segment, Historic, 2000-2008 148
Table 94: Peripheral Vascular Devices, France, Revenue ($ mn) by Segment, Forecast, 2008-2015 150
Table 95: Peripheral Vascular Devices, France, Volume (Units) by Segment, Historic, 2000-2008 152
Table 96: Peripheral Vascular Devices, France, Volume (Units), Forecast, 2008-2015 154
Table 97: Peripheral Vascular Devices, France, Average Price ($), Historic, 2000-2008 155
Table 98: Peripheral Vascular Devices, France, Average Price ($), Forecast, 2008-2015 155
Table 99: Peripheral Vascular Devices, France, Distribution Share by Revenue ($mn), 2007-2008 157
Table 100: Peripheral Vascular Devices, France, Company Share by Revenue ($ mn), 2006-2007 158
Table 101: Cordis Corporation Pipeline Products by Equipment Type 159
Table 102: Cordis Corporation Pipeline Products By Development Stage 160
Table 103: Cordis Corporation Pipeline Products By Therapy Area 161
Table 104: Cordis Corporation Pipeline Products By Clinical Trials 161
Table 105: Cordis Corporation Pipeline Products By News Summaries 161
Table 106: Boston Scientific Corporation Pipeline Products by Equipment Type 165
Table 107: Boston Scientific Corporation Pipeline Products By Development Stage 166
Table 108: Boston Scientific Corporation Pipeline Products By Therapy Area 167
Table 109: Boston Scientific Corporation Pipeline Products By Clinical Trials 168
Table 110: Boston Scientific Corporation Pipeline Products By News Summaries 169
Table 111: Medtronic, Inc. Pipeline Products by Equipment Type 174
Table 112: Medtronic, Inc. Pipeline Products By Development Stage 176
Table 113: Medtronic, Inc. Pipeline Products By Therapy Area 178
Table 114: Medtronic, Inc. Pipeline Products By Clinical Trials 180
Table 115: Medtronic, Inc. Pipeline Products By News Summaries 181
Table 116: Abbott Laboratories Pipeline Products by Equipment Type 185
Table 117: Abbott Laboratories Pipeline Products By Development Stage 185
Table 118: Abbott Laboratories Pipeline Products By Therapy Area 186
Table 119: Abbott Laboratories Pipeline Products By Clinical Trials 186
Table 120: Abbott Laboratories Pipeline Products By News Summaries 186
Table 121: Terumo Corporation Pipeline Products by Equipment Type 189
Table 122: Terumo Corporation Pipeline Products By Development Stage 189
Table 123: Terumo Corporation Pipeline Products By Therapy Area 190
Table 124: Terumo Corporation Pipeline Products By Clinical Trials 190
Table 125: Terumo Corporation Pipeline Products By News Summaries 190
Table 126: Sorin Group Pipeline Products by Equipment Type 196
Table 127: Sorin Group Pipeline Products By Development Stage 198
Table 128: Sorin Group Pipeline Products By Therapy Area 199
Table 129: Sorin Group Pipeline Products By Clinical Trials 200
Table 130: Sorin Group Pipeline Products By News Summaries 200
Table 131: Minvasys Pipeline Products by Equipment Type 204
Table 132: Minvasys Pipeline Products by Equipment Type 204
Table 133: Minvasys Pipeline Products By Therapy Area 204
Table 134: Stentys, S.A.S. Pipeline Products by Equipment Type 205
Table 135: Stentys, S.A.S. Pipeline Products by Development Stage 205
Table 136: Stentys, S.A.S. Pipeline Products By Therapy Area 206
Table 137: Stentys, S.A.S. Pipeline Products By Clinical Trials 206
Table 138: Stentys, S.A.S. Pipeline Products By News Summaries 206
Table 139: Currency Conversion from USD to Local Currency at 2008 Constant Rate 212
Cordis Corporation
Boston Scientific Corporation
Medtronic, Inc.
Abbott Laboratories
Terumo Corporation
Sorin S.p.A.
Balt Extrusion
COMEPA
HEXACATH
Microval Company Profile
Minvasys Company Profile
Novacor
Stentys, S.A.S.
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
